SCHEMBL18017082

SCHEMBL18017082

COc1nc(N2CCNCC2)ncc1C1=C(C)C(=O)OC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 19/20 0.42
▸ ALDH1A1 P00352 18/20 0.42
▸ CASP1 P29466 15/20 0.42
▸ CASP7 P55210 15/20 0.42
▸ CYP3A4 P08684 12/20 0.42
▸ USP2 O75604 11/20 0.42
▸ HSD17B10 Q99714 13/20 0.41
▸ HPGD P15428 12/20 0.41
▸ CYP2C19 P33261 4/20 0.41
▸ TSHR P16473 3/20 0.41
▸ CYP2C9 P11712 5/20 0.41
▸ HTR2C P28335 1/20 0.40
▸ HIF1A Q16665 11/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ GLA P06280 3/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ TP53 P04637 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18017085 0.80 ALDH1A1 (0.45) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL8809371 0.74 ALDH1A1 (0.44) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL17977053 0.74 CYP1A2 (0.43) CYP1A2ALDH1A1CYP3A4CYP2C19TSHR
SCHEMBL18017066 0.72 TGFBR1 (0.41) CYP1A2ALDH1A1CYP3A4USP2CYP2C19
SCHEMBL18017067 0.69 GPR119 (0.51) —
Fumaric Acid SCHEMBL8812798 0.67 HSD17B10 (0.43) CYP1A2ALDH1A1CASP1CASP7CYP3A4
Maleic Acid SCHEMBL8812791 0.67 HSD17B10 (0.43) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL21564400 0.67 ALDH1A1 (0.53) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL8810512 0.65 ALDH1A1 (0.51) CYP1A2ALDH1A1CASP1CASP7CYP3A4
SCHEMBL16466061 0.65 PTPN11 (0.57) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180016263-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME LLC 2018-01-18 — — US disclosed
US-20180016263-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME LLC 2018-01-18 — — US disclosed
WO-2016127358-A1 INHIBITORS OF RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2016-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016263-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL KCNJ11, KCNJ1, SLC9A1 CYP1A2 3242/4885ALDH1A1 1373/4885CASP1 1622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback